On February 11, 2025, the current US government published a website of the US Senate Commerce Committee (Chairman Ted Cruz) announcing the results of an “investigation” into research grants funded by ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) soared 40 percent week-on-week, with the company also experiencing a ...

Recursion Pharmaceuticals RXRX is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for ...

Polymath aims to tackle this by combining gamified mechanics inspired by these popular games with adaptive math lessons to make the learning experience more enjoyable. The educational sandbox game ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

ESET researchers have observed a cluster of North Korea-aligned activities that they named DeceptiveDevelopment and where its ...

The Rutgers University Board of Governors has appointed Matthew Young – an internationally recognized scholar widely regarded ...